NEW DELHI: As the Central Bureau of Investigation (CBI) tightened its probe against officials of Biocon Biologics Limited over the alleged Rs 4 lakh bribe scandal, to waive off the Phase III clinical trial of its underdeveloped product Insulin Aspart Injection, health experts have expressed deep concerns over India’s dependency on insulin and the rising […]